The research team will analyze existing genome-wide association study data and RNA sequencing to compare fibroid development patterns in Nigerian women and U.S. Black women, which could point to targeted therapies and management strategies for affected women.

An international team of experts, including the Uganda Cancer Institute, is developing a groundbreaking mobile breast cancer diagnostic kit to enhance early detection in Uganda, where 70% of cases are diagnosed at an advanced stage.

Building sustainable biomedical informatics training and research capacity to address gaps in Mozambique's national HIV response will help the country leverage newer data-driven and genetics-based approaches for personalized HIV care and molecular epidemiology of the disease.

The long-standing partnership between Vanderbilt Institute for Global Health (VIGH) and collaborators Aminu Kano Teaching Hospital (AKTH) and Bayero University (BUK) is poised to address the growing demand for research in precision medicine in Africa.

Developed in a region with the world’s highest HIV prevalence, this study design and intervention has the potential to impact testing uptake among a “hidden population” by mobilizing trained healers, who vastly outnumber allopathic care providers in South Africa.

Muktar Aliyu, MD, DrPH, MPH, answers questions about the Vanderbilt Institute for Global Health.

A new study will explore the link between salt taste sensitivity and salt intake, blood pressure, hypertension, and genetic variations in individuals of African descent.